Checkmate 205: A phase 2 study of nivolumab in patients with classical Hodgkin lymphoma following autologous stem cell transplantation and brentuximab vedotin Meeting Abstract
| Authors: | Engert, A.; Santoro, A.; Shipp, M.; Zinzani, P. L.; Timmerman, J.; Ansell, S.; Armand, P.; Fanale, M.; Ratanatharathorn, V.; Kuruvilla, J.; Cohen, J.; Collins, G.; Savage, K.; Trneny, M.; Kato, K.; Farsaci, B.; Parker, S.; Rodig, S.; Younes, A. |
| Abstract Title: | Checkmate 205: A phase 2 study of nivolumab in patients with classical Hodgkin lymphoma following autologous stem cell transplantation and brentuximab vedotin |
| Meeting Title: | 21st Congress of the European Hematology Association (EHA) |
| Journal Title: | Haematologica |
| Volume: | 101 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2016 Jun 9-12 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2016-06-01 |
| Start Page: | 319 |
| Language: | English |
| ACCESSION: | WOS:000379484601155 |
| PROVIDER: | wos |
| PMCID: | PMC4894295 |
| Notes: | Meeting Abstract: S793 -- Source: Wos |
MSK Authors
-
319Younes